New data indicates an aggressive Vitamin D treatment plan should be considered when caring for all Osteoporosis patients. Doing so may help decrease their likelihood of developing Vitamin D deficiency. These findings will be presented at the American Association of Clinical Endocrinologists (AACE) 17th Annual Meeting & Clinical by Harinder Singh, MD on Friday, May 16th at the Walt Disney World Dolphin Resort in Orlando.
“Our research suggests that Vitamin D deficiency is quite prevalent in patients with Osteoporosis,” Dr. Singh said. “Much more so than was originally believed.”
Singh will present how his research showed an alarming rate of Vitamin D deficiency amongst patients being treated for Osteoporosis and furthermore, how it should be met with an “aggressive” treatment regimen.
Research on the topics of Vitamin D and Osteoporosis will be a major highlight at this year’s meeting. Two major sessions include “Osteoporosis: What’s New and What’s Next,” where AACE Member Nelson Watts MD, FACP, MACE will discuss a possible once-a-year treatment for Osteoporosis. The other session, “Vitamin D Deficiency: A Near Universal Health Problem,” will focus on how adequate vitamin D intake may help reduce the severity of chronic endocrine-related diseases.
About the AACE Annual Meeting
American Association of Clinical Endocrinologists